Drugs / Advante
Advante
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00168051 | Apr → Nov 2005 | hemophilia A | Wyeth is now a wholly owned subsidiary of Pfizer | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Advante | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00168051 ↗ |
| Known as | FLrFVIII | “Advante (a Full-length Recombinant Factor VIII (FLrFVIII)” NCT00168051 ↗ |
| Known as | Full-length Recombinant Factor VIII | “Advante (a Full-length Recombinant Factor VIII (FLrFVIII)” NCT00168051 ↗ |
| Modality | Protein / enzyme biologic | “Full-length Recombinant Factor VIII” NCT00168051 ↗ |